Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
21.40    0.20 (0.94%)
Bid:
21.40
Ask:
22.40
Spread: 1.00 (4.673%)
Market Cap: €118.73b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

BBVA DIVIDEND OPTION Information note

15 Sep 2011 07:54

RNS Number : 2892O
Banco Bilbao Vizcaya Argentaria SA
15 September 2011
 

 

 

 

 

 

 

Banco Bilbao Vizcaya Argentaria, S.A. (BBVA), pursuant to the provisions of the Spanish Securities Market Act, hereby proceeds by means of the present document to notify the following:

 

 

RELEVANT EVENT 

 

 

BBVA hereby communicates relevant information relating to the free-of-charge capital increase resolved by the General Meeting of BBVA shareholders held on 11th March 2011, under agenda item five, section 5.2, by which a system of flexible shareholder remuneration called "Dividend Option" is to be instrumented. Accompanying this relevant event notice is an information note which indicates the expected timetable and other matters related to the Dividend Option.

 

 

 

 

Madrid, 15th September 2011

INFORMATION NOTE

 

 

 

The General Meeting of Banco Bilbao Vizcaya Argentaria, S.A. shareholders, under agenda item five, section 5.2, approved a free-of-charge capital increase for the instrumentation of the system of shareholder remuneration called "Dividend Option", which permits shareholders to elect to receive the amount corresponding to one of the traditional cash dividends of 2011 in BBVA shares or, at their election, in cash.

 

The execution of such free-of-charge capital increase will be proposed for consideration by BBVA's Board of Directors at its 27th September 2011 meeting, with the effect that the Dividend Option could be implemented during October, generally coinciding with the typical dates of payment of the second interim dividend.

 

If BBVA's Board of Directors approves the execution of such free-of-charge capital increase, it is expected to be executed in accordance with the following timetable:

 

·; 27th September 2011: Communication of the number of rights necessary to receive one new share, and the definitive price at which BBVA has committed to purchase rights.

 

·; 29th September 2011 (23:59 Madrid time): Record date for allocation of rights.

 

·; 30th September 2011: Rights trading period begins in Spain.

 

·; 10th October 2011: Deadline for requesting payment in cash (sale of rights to BBVA).

 

·; 14th October 2011: Rights trading period ends.

 

·; 19th October 2011: Payment date to shareholders who have requested payout in cash (sale of rights to BBVA).

 

·; 21st October 2011: New shares allocated to shareholders.

 

·; 24th October 2011: Initiation of ordinary trading of the new shares on the Spanish exchanges, subject to obtaining all necessary authorisations.

 

Finally, it is estimated that, assuming BBVA's Board of Directors approves the execution of such free-of-charge capital increase, the approximate purchase price at which BBVA will purchase rights, in accordance with the formula approved by the General Meeting of BBVA shareholders, will be around 0.10 euros per right.

 

Madrid, 15th September 2011

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PDIKMGMLVKFGMZG
Date   Source Headline
19th Dec 20195:48 pmRNSAdjustment Goodwill Group investment in the USA
5th Dec 201911:48 amRNSSREP Capital Requirements 2020
19th Nov 20196:30 pmRNSMREL Requirement
12th Nov 20198:50 amRNSPost-Stabilisation Notice - BBVA
31st Oct 20197:04 amRNS3Q19 Results Presentation
31st Oct 20197:00 amRNS3Q19 Results Report
31st Oct 20197:00 amRNS3Q19 Results Press Release
21st Oct 20195:05 pmRNS3Q19 Results Presentation Announcement
8th Oct 20197:41 amRNSCorporate Transactions
3rd Oct 20197:00 amRNSDividend October 2019
30th Sep 20197:00 amRNSRelevant Information DCN
24th Sep 20198:15 amRNSPre-Stabilisation Notice - BBVA
29th Aug 20197:00 amRNSOffer of securities contingently convertible
28th Aug 20197:00 amRNSPreferred securities contingently convertible
8th Aug 20197:00 amRNSSale of BBVA Paraguay
5th Aug 201912:07 pmRNSPost-Stabilisation Notice - BBVA
31st Jul 20198:18 amRNS2Q19 Results Report
31st Jul 20198:14 amRNS2Q19 Results Presentation
31st Jul 20197:08 amRNS2Q19 Results Press Release
18th Jul 20195:32 pmRNS2Q19 Results Presentation Announcement
4th Jul 20195:19 pmRNSFitch Ratings upgrade
21st Jun 20195:25 pmRNSTransfer of credits rights
12th Jun 20198:03 amRNSPre-Stabilisation Notice - BBVA
29th Apr 20195:24 pmRNSAppointments at the board of Directors
29th Apr 20195:20 pmRNS1Q19 Results Presentation
29th Apr 20195:08 pmRNS1Q19 Results Press Release
29th Apr 20195:06 pmRNS1Q19 Results Report
26th Apr 201910:41 amRNS2018 Audited Financial Statements
25th Apr 201910:48 amRNSPost Stabilisation Notice
17th Apr 201910:48 amRNS1Q19 Results Presentation Announcement
12th Apr 20197:00 amRNSGlobal Medium Term Programme - Venue change
20th Mar 201910:52 amRNSPost Stabilisation Notice - BBVA
20th Mar 20197:00 amRNSIssue of securities convertible into BBVA shares
19th Mar 201910:42 amRNSPre Stabilisation Notice
18th Mar 20193:42 pmRNSPrudential Relevance Report Pillar III in 2018
18th Mar 20193:36 pmRNSResolutions adopted by the AGM
20th Feb 20197:00 amRNSRedemption of Subordinated Notes
15th Feb 20197:00 amRNSCapital Requirements for 2019
13th Feb 20198:02 amRNS2019 AGM Proposed Resolutions
12th Feb 20197:00 amRNSFinal dividend calendar 2018
11th Feb 20196:07 pmRNS2019 Annual General Meeting Call
1st Feb 20197:00 amRNSFinal dividend for 2018
1st Feb 20197:00 amRNS4Q18 Results Report
1st Feb 20197:00 amRNS4Q18 Results Press Release
1st Feb 20197:00 amRNS4Q18 Results Presentation
28th Jan 20195:38 pmRNS4Q18 Results Presentation Announcement
16th Jan 20197:00 amRNSRedemption of securities contingently convertible
16th Jan 20197:00 amRNSRedemption of securities contingently convertible
27th Dec 20187:00 amRNSAgreement with Voyager Investing UK Limited
24th Dec 20187:00 amRNSBBVA gives full effect to its succession plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.